组织内存T细胞在癌症转移控制中
Tyler H Montgomery1, Anuj P Master1, Zeng Jin1
1Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL 32610, USA.
Cells
|August 27, 2025
概括
组织内存T细胞 (TRM) 是控制癌症传播的关键. 本综述探讨了TRM细胞在不同癌症中的作用以及如何使用它们来对抗转移.
科学领域:
- 免疫学
- 癌症学
- 细胞生物学
背景情况:
- 组织内存T细胞 (TRM) 对于抗癌免疫非常重要.
- 它们在各种瘤类型和组织中转移的具体功能尚未完全理解.
研究的目的:
- 审查TRM细胞参与癌症转移的机制.
- 讨论治疗策略和TRM细胞作为生物标志物的潜力.
主要方法:
- 对癌症转移中的TRM细胞的当前研究的文献综述.
- 对TRM细胞播种,保留,效应器功能和与瘤微环境的相互作用进行分析.
主要成果:
- 在消除扩散的瘤细胞方面,TRM细胞起着至关重要的作用.
- 有证据表明TRM细胞介导免疫的器官特异性.
- TRM细胞与局部肌肉细胞和骨髓细胞进行动态相互作用.
结论:
- 通过疫苗接种和检查点调节等疗法利用TRM细胞功能是有希望的.
- TRM细胞可以作为转移性疾病的宝贵预后生物标志物.
- 需要进一步的研究来将TRM细胞生物学转化为有效的抗转移干预措施.
相关概念视频
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Cell-mediated Immune Responses
72.4K
Overview
72.4K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
Cytotoxic T Cells-mediated Immune Response
1.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.9K


